SMAD2 and cancer: LincRoR has been shown to modulate cancer progression via interaction with microRNA-145 [47], and microRNA-145-5p was shown to ameliorate hypertrophic scar through suppression of myofibroblast activation and reduction of Smad2/3 [53].